Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ULTRACET add-on therapy for Rheumatoid Arthritis pain
NCT00246168Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of tramadol hydrochloride + acetaminophen in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Status: completed.
02
Drugs
tramadol hydrochloride + acetaminophen
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00246168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246168.